Hypoxia differentially upregulates the expression of embryonic, fetal and adult hemoglobin in human glioblastoma cells

International Journal of Oncology

Volumn 44, Issue 3, 2014, Pages 950-958

  Emara, Marwan ^a,b   Turner, A Robert ^a   Allalunis Turner, Joan ^a  

^a ALBERTA HEALTH SERVICES   (Canada)

^b Zewail City of Science and Technology   (Egypt)

Author keywords

Glioblastoma multiforme; Hemoglobin; Hypoxia

Indexed keywords

CD133 ANTIGEN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN DELTA CHAIN; HEMOGLOBIN EPSILON CHAIN; HEMOGLOBIN GAMMA CHAIN; HEMOGLOBIN ZETA CHAIN; MESSENGER RNA;

ARTICLE; CANCER STEM CELL; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

BRAIN NEOPLASMS; CELL HYPOXIA; ERYTHROPOIETIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HEMOGLOBINS; HUMANS; NEOPLASTIC STEM CELLS; RECEPTORS, ERYTHROPOIETIN;

EID: 84896702781     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2239     Document Type: Article

References (74)

1. Egawa T and Yeh SR: Structural and functional properties of hemoglobins from unicellular organisms as revealed by resonance Raman spectroscopy. J Inorg Biochem 99: 72-96, 2005.
2. Wajcman H, Kiger L and Marden MC: Structure and function evolution in the superfamily of globins. C R Biol 332: 273-282, 2009.
3. Pesce A, Bolognesi M, Bocedi A, et al: Neuroglobin and cytoglobin. Fresh blood for the vertebrate globin family. EMBO Rep 3: 1146-1151, 2002.
4. Schelshorn DW, Schneider A, Kuschinsky W, et al: Expression of hemoglobin in rodent neurons. J Cereb Blood Flow Metab 29: 585-595, 2009.
5. Ohyagi Y, Yamada T and Goto I: Hemoglobin as a novel protein developmentally regulated in neurons. Brain Res 635: 323-327, 1994.
6. Biagioli M, Pinto M, Cesselli D, et al: Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci USA 106: 15454-15459, 2009.
7. Dassen H, Kamps R, Punyadeera C, et al: Haemoglobin expression in human endometrium. Hum Reprod 23: 635-641, 2008.
8. Liu L, Zeng M and Stamler JS: Hemoglobin induction in mouse macrophages. Proc Natl Acad Sci USA 96: 6643-6647, 1999.
9. Wride MA, Mansergh FC, Adams S, et al: Expression profiling and gene discovery in the mouse lens. Mol Vis 9: 360-396, 2003.
10. Nishi H, Inagi R, Kato H, et al: Hemoglobin is expressed by mesangial cells and reduces oxidant stress. J Am Soc Nephrol 19: 1500-1508, 2008.
11. Bhaskaran M, Chen H, Chen Z and Liu L: Hemoglobin is expressed in alveolar epithelial type II cells. Biochem Biophys Res Commun 333: 1348-1352, 2005.
12. Newton DA, Rao KM, Dluhy RA and Baatz JE: Hemoglobin is expressed by alveolar epithelial cells. J Biol Chem 281: 5668-5676, 2006.
13. Gorr TA, Wichmann D, Pilarsky C, et al: Old proteins - new locations: myoglobin, haemoglobin, neuroglobin and cytoglobin in solid tumours and cancer cells. Acta Physiol (Oxf) 202: 563-581, 2011.
14. Hardison RC: Globin genes on the move. J Biol 7: 35, 2008.
15. Bunn HF and Forget BG: Hemoglobin: Molecular, Genetic and Clinical Aspects. W.B. Saunders Co, Philadelphia, PA, 1986.
16. Cosby K, Partovi KS, Crawford JH, et al: Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9: 1498-1505, 2003.
17. Huang Z, Shiva S, Kim-Shapiro DB, et al: Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 115: 2099-2107, 2005.
18. Masuoka N, Kodama H, Abe T, Wang DH and Nakano T: Characterization of hydrogen peroxide removal reaction by hemoglobin in the presence of reduced pyridine nucleotides. Biochim Biophys Acta 1637: 46-54, 2003.
19. Gross SS and Lane P: Physiological reactions of nitric oxide and hemoglobin: a radical rethink. Proc Natl Acad Sci USA 96: 9967-9969, 1999.
20. Tsiftsoglou AS, Vizirianakis IS and Strouboulis J: Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 61: 800-830, 2009.
21. Rogers HM, Yu X, Wen J, Smith R, Fibach E and Noguchi CT: Hypoxia alters progression of the erythroid program. Exp Hematol 36: 17-27, 2008.
22. Sakanaka M, Wen TC, Matsuda S, et al: In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95: 4635-4640, 1998.
23. Tan CC, Eckardt KU, Firth JD and Ratcliffe PJ: Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol 263: F474-F481, 1992.
24. Tezel G, Yang X, Luo C, et al: Hemoglobin expression and regulation in glaucoma: insights into retinal ganglion cell oxygenation. Invest Ophthalmol Vis Sci 51: 907-919, 2010.
25. Lim SK, Llaguno SR, McKay RM and Parada LF: Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models. BMB Rep 44: 158-164, 2011.
26. Chaudhry NS, Shah AH, Ferraro N, et al: Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century. Cancer Invest 31: 287-308, 2013.
27. Bar EE: Glioblastoma, cancer stem cells and hypoxia. Brain Pathol 21: 119-129, 2011.
28. Sathornsumetee S, Cao Y, Marcello JE, et al: Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan. J Clin Oncol 26: 271-278, 2008.
29. 2 availability on human cancer. Nat Rev Cancer 8: 967-975, 2008.
30. Alves TR, Lima FR, Kahn SA, et al: Glioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchyma. Life Sci 89: 532-539, 2011.
31. Emara M, Salloum N and Allalunis-Turner J: Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells. Mol Oncol 3: 45-53, 2009.
32. Emara M, Turner AR and Allalunis-Turner J: Hypoxic regulation of cytoglobin and neuroglobin expression in human normal and tumor tissues. Cancer Cell Int 10: 33, 2010.
33. Fang J, Ma I and Allalunis-Turner J: Knockdown of cytoglobin expression sensitizes human glioma cells to radiation and oxidative stress. Radiat Res 176: 198-207, 2011.
34. Emara M, Turner AR and Allalunis-Turner J: Adult, embryonic, and fetal hemoglobin are expressed in human glioblastoma cells. Int J Oncol 44: 514-520, 2014.
35. Allalunis-Turner MJ, Barron GM, Day RS III, Dobler KD and Mirzayans R: Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res 134: 349-354, 1993.
36. Allalunis-Turner MJ, Barron GM, Day RS III, Fulton DS and Urtasun RC: Radiosensitivity testing of human primary brain tumor specimens. Int J Radiat Oncol Biol Phys 23: 339-343, 1992.
37. Allalunis-Turner MJ, Franko AJ and Parliament MB: Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia. Br J Cancer 80: 104-109, 1999.
38. Parliament MB, Allalunis-Turner MJ, Franko AJ, et al: Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours. Br J Cancer 82: 635-641, 2000.
39. Johnston AL, Lun X, Rahn JJ, et al: The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol 5: e212, 2007.
40. Koch CJ, Howell RL and Biaglow JE: Ascorbate anion potentiates cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions. Br J Cancer 39: 321-329, 1979.
41. Kelly JJ, Stechishin O, Chojnacki A, et al: Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells 27: 1722-1733, 2009.
42. Mohyeldin A, Dalgard CL, Lu H, et al: Survival and invasiveness of astrocytomas promoted by erythropoietin. J Neurosurg 106: 338-350, 2007.
43. Said HM, Hagemann C, Staab A, et al: Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol 83: 398-405, 2007.
44. Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G and Pelicci G: CD133 is essential for glioblastoma stem cell maintenance. Stem Cells 31: 857-869, 2013.
45. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003.
46. + cancer stem cells in glioblastoma. Mol Cancer 5: 67, 2006.
47. Pallini R, Ricci-Vitiani L, Montano N, et al: Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer 117: 162-174, 2011.
48. He Y, Hua Y, Liu W, Hu H, Keep RF and Xi G: Effects of cerebral ischemia on neuronal hemoglobin. J Cereb Blood Flow Metab 29: 596-605, 2009.
49. Rebetz J, Tian D, Persson A, et al: Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS One 3: e1936, 2008.
50. Valtz NL, Hayes TE, Norregaard T, Liu SM and McKay RD: An embryonic origin for medulloblastoma. New Biol 3: 364-371, 1991.
51. Schechter AN: Hemoglobin research and the origins of molecular medicine. Blood 112: 3927-3938, 2008.
52. Crawford MJ and Goldberg DE: Regulation of the Salmonella typhimurium flavohemoglobin gene. A new pathway for bacterial gene expression in response to nitric oxide. J Biol Chem 273: 34028-34032, 1998.
53. Richter F, Meurers BH, Zhu C, Medvedeva VP and Chesselet MF: Neurons express hemoglobin alpha- and beta-chains in rat and human brains. J Comp Neurol 515: 538-547, 2009.
54. Acs G, Acs P, Beckwith SM, et al: Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 61: 3561-3565, 2001.
55. Batra S, Perelman N, Luck LR, Shimada H and Malik P: Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 83: 1477-1487, 2003.
56. Marti HH, Wenger RH, Rivas LA, et al: Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8: 666-676, 1996.
57. Olive PL, Trotter T, Banath JP, Jackson SM and Le Riche J: Heterogeneity in human tumour hypoxic fraction using the comet assay. Br J Cancer (Suppl) 27: S191-S195, 1996.
58. 2 tension measurements. Cancer Res 51: 3316-3322, 1991.
59. Foley RN: Erythropoietin: physiology and molecular mechanisms. Heart Fail Rev 13: 405-414, 2008.
60. Jelkmann W, Bohlius J, Hallek M and Sytkowski AJ: The erythropoietin receptor in normal and cancer tissues. Crit Rev Oncol Hematol 67: 39-61, 2008.
61. Milano M and Collomp R: Erythropoietin and neuroprotection: a therapeutic perspective. J Oncol Pharm Pract 11: 145-149, 2005.
62. Yasuda Y, Fujita Y, Matsuo T, et al: Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 24: 1021-1029, 2003.
63. Yin D, Kawabata H, Tcherniamtchouk O, Huynh T, Black KL and Koeffler HP: Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin. Int J Oncol 31: 1193-1198, 2007.
64. Hassouna I, Sperling S, Kim E, et al: Erythropoietin augments survival of glioma cells after radiation and temozolomide. Int J Radiat Oncol Biol Phys 72: 927-934, 2008.
65. Wood WG: Haemoglobin synthesis during human fetal development. Br Med Bull 32: 282-287, 1976.
66. Allen DW and Jandl JH: Factors influencing relative rates of synthesis of adult and fetal hemoglobin in vitro. J Clin Invest 39: 1107-1113, 1960.
67. Thomas ED, Lochte HL Jr, Greenough WB III and Wales M: In vitro synthesis of foetal and adult haemoglobin by foetal haematopoietic tissues. Nature 185: 396-397, 1960.
68. Seidel S, Garvalov BK, Wirta V, et al: A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 133: 983-995, 2010.
69. Soeda A, Park M, Lee D, et al: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28: 3949-3959, 2009.
70. Bao S, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006.
71. Tamura K, Aoyagi M, Wakimoto H, et al: Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation. J Neurosurg 113: 310-318, 2010.
72. Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn HM and Held-Feindt J: Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol 86: 31-45, 2008.
73. Sankaran VG: Targeted therapeutic strategies for fetal hemoglobin induction. Hematology Am Soc Hematol Educ Program 2011: 459-465, 2011.
74. Witt O, Monkemeyer S, Ronndahl G, et al: Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 101: 2001-2007, 2003.